Do air gaps with image-guided vaginal cuff brachytherapy impact failure rates in patients with high-intermediate risk FIGO Stage I endometrial cancer?


Journal

Brachytherapy
ISSN: 1873-1449
Titre abrégé: Brachytherapy
Pays: United States
ID NLM: 101137600

Informations de publication

Date de publication:
Historique:
received: 29 09 2020
revised: 20 11 2020
accepted: 20 11 2020
pubmed: 2 1 2021
medline: 12 10 2021
entrez: 1 1 2021
Statut: ppublish

Résumé

The aim of this study was to assess the impact of air gaps at the cylinder surface on the rate of vaginal cuff failure (VCF) after image-guided adjuvant vaginal cuff brachytherapy (VCBT) in the treatment of high-intermediate risk (HIR) FIGO (Fédération Internationale de Gynécologie et d'Obstétrique (International Federation of Gynecology and Obstetrics)) Stage I endometrial cancer. A retrospective review of patients treated with image-guided VCBT from 2009 to 2016 for HIR FIGO Stage I endometrial cancer was performed. Air gaps present at the applicator surface on the first postinsertion CT were contoured. Vaginal cuff failure-free survival (VCFFS) was measured from the first fraction of VCBT to VCF. A total of 234 patients were identified. Air gaps were present on the first postinsertion CT scan in 82% of patients. The median number of air gaps was 2 (interquartile range [IQR] 1-3), median depth of the largest air gap was 2.7 mm (IQR 2.1-3.4 mm), and the median cumulative volume of air gaps was less than 0.1 cm In this population, VCFFS remained high despite most patients having air gaps present on postinsertion CT scan.

Identifiants

pubmed: 33384254
pii: S1538-4721(20)30256-7
doi: 10.1016/j.brachy.2020.11.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

512-518

Informations de copyright

Copyright © 2020 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Adam H Richman (AH)

Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Ankur K Patel (AK)

Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Joshua L Rodríguez-López (JL)

Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Andrew Keller (A)

Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.

John A Vargo (JA)

Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Hayeon Kim (H)

Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Paniti Sukumvanich (P)

Department of Gynecologic Oncology, UPMC Magee-Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Jessica L Berger (JL)

Department of Gynecologic Oncology, UPMC Magee-Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Michelle M Boisen (MM)

Department of Gynecologic Oncology, UPMC Magee-Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Robert Edwards (R)

Department of Gynecologic Oncology, UPMC Magee-Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Sarah E Taylor (SE)

Department of Gynecologic Oncology, UPMC Magee-Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Madeleine B Courtney-Brooks (MB)

Department of Gynecologic Oncology, UPMC Magee-Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Alexander Olawaiye (A)

Department of Gynecologic Oncology, UPMC Magee-Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Brian C Orr (BC)

Department of Gynecologic Oncology, UPMC Magee-Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Jamie L Lesnock (JL)

Department of Gynecologic Oncology, UPMC Magee-Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Sushil Beriwal (S)

Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA. Electronic address: beriwals@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH